Хаврикс (Доза За Деца)

Хаврикс (Доза За Деца) is an inactivated hepatitis A vaccine designed for pediatric use. This EU-manufactured injection helps protect children from hepatitis A virus infection. Ideal for travel or routine immunization, it provides long-term immunity with a single dose.

Хаврикс (Доза За Деца) is used to prevent hepatitis A virus infection in children. It stimulates the immune system to produce antibodies against the virus, offering protection before potential exposure. This vaccine is commonly recommended for travel to regions with high hepatitis A prevalence or as part of routine childhood immunization schedules.

After administration, the vaccine triggers an immune response that may cause mild, temporary effects such as soreness at the injection site or low-grade fever. Some children may experience fatigue or mild headache, which typically resolve within a few days. These effects indicate the body is building protection against the virus.

Store the vaccine refrigerated between 2°C and 8°C and protect it from light. Do not freeze. Ensure the child is healthy at the time of vaccination, as minor illnesses may delay administration. Always inform the healthcare provider about any allergies or previous reactions to vaccines or components like neomycin.

This vaccine may interact with immunosuppressive therapies, reducing its effectiveness. Avoid receiving other vaccines simultaneously unless recommended by a healthcare professional. Live vaccines should not be given within 4 weeks of this vaccine unless medically advised. Always disclose current medications or treatments to the administering healthcare provider.